Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma
serplulimab联合贝伐珠单抗生物类似药HLX04一线治疗晚期肝细胞癌的II期研究
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-024-03917-w
Ren, Zhenggang; Shao, Guoliang; Shen, Jie; Zhang, Li; Zhu, Xu; Fang, Weijia; Sun, Guoping; Bai, Yuxian; Wu, Jianbing; Liu, Lianxin; Yuan, Yuan; Zhang, Jingdong; Li, Zhen; Zhang, Ling; Yin, Tao; Wu, Jincai; Hou, Xiaoli; Yu, Haoyu; Li, Jing; Wang, Qingyu; Zhu, Jun; Fan, Jia